BCM
LFCR icon

Buckhead Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Buckhead Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50,230
Closed -$656K – 119
2018
Q1 		$656K Buy
50,230
+6,720
+15% +$88.3K 0.14% 124
2017
Q4 		$548K Buy
43,510
+3,400
+8% +$43K 0.12% 134
2017
Q3 		$519K Hold
40,110
– – 0.11% 135
2017
Q2 		$596K Hold
40,110
– – 0.11% 130
2017
Q1 		$481K Buy
40,110
+11,605
+41% +$147K 0.09% 135
2016
Q4 		$393K Sell
28,505
-7,400
-21% -$103K 0.07% 139
2016
Q3 		$481K Sell
35,905
-36,500
-50% -$442K 0.09% 139
2016
Q2 		$779K Sell
72,405
-23,533
-25% -$260K 0.14% 120
2016
Q1 		$1.01M Buy
95,938
+20,131
+27% +$221K 0.19% 114
2015
Q4 		$897K Buy
75,807
+710
+0.9% +$8.72K 0.17% 124
2015
Q3 		$876K Buy
75,097
+438
+0.6% +$5.8K 0.17% 126
2015
Q2 		$1.08M Hold
74,659
– – 0.2% 116
2015
Q1 		$1.04M Sell
74,659
-29,295
-28% -$405K 0.18% 118
2014
Q4 		$1.44M Hold
103,954
– – 0.25% 114
2014
Q3 		$1.27M Sell
103,954
-6,135
-6% -$76.6K 0.22% 115
2014
Q2 		$1.38M Sell
110,089
-69,700
-39% -$820K 0.19% 135
2014
Q1 		$2.01M Buy
+179,789
New +$1.97M 0.25% 132

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Buckhead Capital Management's LFCR Position: Q2 2018 in Review

Buckhead Capital Management sold out of Lifecore Biomedical (LFCR) in Q2 2018, closing a stake of 50,230 shares — an estimated $656K sold.

Buckhead Capital Management first reported a position in LFCR in Q1 2014 and held it in 17 quarters. The position peaked at $2.01M in Q1 2014. 92 funds tracked by Wall St. Rank hold LFCR as of Q2 2018.

  • Buckhead Capital Management reported no remaining Lifecore Biomedical position as of Q2 2018 after selling out during the quarter.
  • Buckhead Capital Management sold 50,230 Lifecore Biomedical shares in Q2 2018, an estimated $656K.
  • Buckhead Capital Management first reported a position in Lifecore Biomedical in Q1 2014 and held it in 17 quarters.
  • Buckhead Capital Management's Lifecore Biomedical position peaked at $2.01M in Q1 2014.
  • 92 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2018.

Based on Buckhead Capital Management's 13F filing for Q2 2018, filed 2 Aug 2018.